Tradestie Institutional Equity Comparison Engine
SRTM vs TVGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TVGN Overall Edge
TVGN Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tevogen Bio Holdings Inc. Common Stock (TVGN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SRTM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TVGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SRTM N/M vs TVGN N/M Fwd P/E
Growth & Margin Winner
TVGN
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
TVGN
1Y -86.8% vs +1342.5% ยท 52W Pos 2% vs 48%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SRTM
US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap
N/A
1M Return
-80.4%
1Y Return
-86.83%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
TVGN
NASDAQ
Tevogen Bio Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$5.90
-6.35% 1D
Market Cap
$432.7M
1M Return
-13.36%
1Y Return
+1342.54%
Forward P/E
N/M
Unified AI Score
51.6 / 100
HOLD
Tech 42.0
Fund 51.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SRTM -86.83%
TVGN +1342.54%
Spread: +73.98 pp (TVGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SRTM TTM Op. Margin: N/A
TVGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRTM vs TVGN. Trailing 12-month operating profitability (SRTM N/A vs TVGN 0.0%) and valuation multiples (SRTM N/M vs TVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SRTM | TVGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $432.7M | Larger Scale | TVGN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | TVGN |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | TVGN |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | TVGN |
| Return on Equity (ROE) Capital Efficiency | N/A | 0.0% | Higher ROE | TVGN |
| 52-Week Range Position Momentum | 2% ($0โ$1) | 48% ($0โ$12) | Stronger Trend | TVGN |
| Beta / 30D Volatility Risk Regime | N/A | 1.32ฮฒ ยท 69% Vol | Lower Realized Risk | TVGN |
| Unified Institutional Score Composite Signal | 47.6 / 100 (HOLD) | 51.6 / 100 (HOLD) | Higher Composite | TVGN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SRTM vs TVGN Buy Guide
SRTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TVGN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SRTM nor TVGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.